Univdatos Whatsapp
Brain Modalities and Software Market

Brain Modalities and Software Market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

Brain modalities and software devices are used to monitor and diagnose neurological diseases by exploring the structure and function of the brain. This process involves the use of several brain modalities and software devices such as magnetic resonance imaging scanners, computerized tomography scanners, and positron emission tomography scanners to track brain functions. In addition, these devices help monitor neural and electrical activity in the brain. At present, there is an increase in the demand for computerized tomography scanners among healthcare providers. Thus, the global brain modalities and software market is expected to grow at a CAGR of ~5% from 2021-2027.

For a detailed analysis of the brain modalities and software market browse through https://univdatos.com/report/brain-modalities-and-software-market/

The growth of this market is driven owing by the increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. For instance, according to World Health Organization (WHO), in September 2021 more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. It is one of the major causes of disability and dependency among older people worldwide. Also, in 2019, globally, 50 million people were diagnosed with epilepsy. According to World Health Organization (WHO), nearly 80% population live in low- and middle-income countries.

The increasing prevalence of neurological disorders over many years, like Parkinson’s disease, Epilepsy, Alzheimer’s disease, and others act as the major factors in driving the growth of the Brain Modalities and Software Market. This can primarily be attributed to the growing geriatric population. According to World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

However, some of the restraints in the market are the high cost of complex Brain Modalities and Software procedures and devices, stringent government regulations, and unfavorable reimbursement policies. The high cost associated with the integration and installation of devices is a major factor restraining the market. For instance, the average cost of a standard (Electroencephalogram) EEG is around USD 200–700; this procedure can cost as high as USD 3,000 for extended monitoring. A dual-channel total cost of development (TCD) costs approximately USD 3,000–3,200, and an ICP monitor costs approximately USD 340–500. Likewise, a single MEG system costs roughly USD 2.5–3 million. Due to the high price, healthcare facilities, even in countries that show wide adoption of high-tech medical equipment, find it difficult to procure MEG devices. Additionally, the maintenance cost and other associated indirect expenses increase the total cost of ownership of these devices, thereby limiting their adoption.

For a detailed analysis of the market drivers of brain modalities and software market browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=20835

Based on offering, the brain modalities and software market is bifurcated into brain imaging modalities, and brain analysis software. Among these, the brain imaging modalities category held the largest share in the market. This is mainly due to the rising incidence of neurological, traumatic brain injuries, psychotic, and sleep disorders, the need for early diagnosis, and increasing patient awareness.

Based on patient type, the market is categorized into adults, pediatrics & infants. Among these, the pediatrics & infants category is projected to witness significant growth during the forecast period. Some neurological conditions are inborn, caused by birthing mishaps, such as hemorrhage, asphyxia, hydrocephalus, a viral or bacterial infection contracted during pregnancy, delivery, or after birth, and use of alcohol or drugs during pregnancy. Furthermore, rising incidences of traumatic brain injuries is also a key factor driving the market.

For a detailed analysis of the segments of Brain Modalities and Software market browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=20835

Based on application, the brain modalities and software market is segmented into traumatic brain injury (TBI), Headache Disorders, Epilepsy, Sleep Disorders, Parkinson’s Disease, Stroke, Huntington’s Disease, Dementia, and others. In 2020, TBI held a significant share in the market. This is mainly due to the growing incidence of traumatic brain injuries across the globe, leading to high demand for the efficient diagnosis and treatment of these cases, thus requiring the intensive use of brain modalities and software devices.

Based on end-users, the brain modalities and software devices market is segmented into hospitals & clinics, neurology centers, ambulatory surgery centers (ACS), and diagnostic image centers. The diagnostic image centers is expected to hold a dominant position during the forecast period. Brain modalities and software is a complex process, requiring expensive and advanced devices and equipment that are mainly found in diagnostic image centers. Additionally, brain modalities and software devices pose a considerable burden in terms of maintenance expenses on healthcare facilities, more than other end-users.

For a better understanding of the market adoption, the report provides a detailed analysis of major regions and countries including North America (US, Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), and Rest of World. North America is expected to dominate the brain modalities and software market due to the growing incidence of neurological diseases coupled with rising expenditure on development of advance products and systems for treatment of various neurological and other diseases. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to the increase in the geriatric population.

For a detailed analysis of the segments of Brain Modalities and Software market browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=20835

Some of the major key players operating in the market include Vuno Co. Ltd., Fujifilm Holdings Corporation, Imaging Biometrics LLC, A.I. Analysis Inc., Aspect Imaging Ltd., IXICO plc, Mint Labs Inc., Medtronic, CAS Medical Systems, Inc., Drägerwerk AG & Co. KGaA.

Brain Modalities and Software Market Segmentation

Market Insight, on offering

  • Brain Imaging Modalities
  • Brain Analysis Software

Market Insight, by patients

  • Adults
  • `

Market Insight, by Application

  • Headache Disorders
  • Epilepsy
  • Sleep Disorders
  • Parkinson’s Disease
  • Traumatic Brain Injury (TBI)
  • Stroke
  • Huntington’s Disease
  • Dementia
  • Others

Market Insight, by End-User

  • Hospitals & Clinics
  • Neurology Centers
  • Ambulatory Surgery Centers (ASCs)
  • Diagnostic Centers

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Vuno Co. Ltd.
  • Fujifilm Holdings Corporation
  • Imaging Biometrics LLC
  • A.I. Analysis Inc.
  • Aspect Imaging Ltd.
  • IXICO plc
  • Mint Labs Inc.
  • Medtronic
  • CAS Medical Systems, Inc.
  • Drägerwerk AG & Co. KGaA

Leave A Comment

Select Language